Search research articles
Contact Us
Filters
Showing results (1221-1230 of 1,388) with videos related to
Page
of 139
Sort By:
The Lancet. Oncology
|
October 28, 2017
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Alice T Shaw, Enriqueta Felip, Todd M Bauer, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Genetically-programmed Hypervesiculation of <i>Lactiplantibacillus plantarum</i> Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease Model
Nicholas H Pirolli, Daniel Levy, Alyssa Schledwitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 15, 2017
Exercise to preserve β-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) - a randomized controlled pilot trial
P Narendran, N Jackson, A Daley, et al.
Respiratory Medicine
|
April 22, 2017
High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival
Zulma X Yunt, Jonathan H Chung, Stephen Hobbs, et al.
Neurology. Clinical Practice
|
January 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS
Maria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, et al.
Heart Rhythm
|
April 27, 2005
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM
Katherine T Murray, Jeffrey N Rottman, Patrick G Arbogast, et al.
Respiratory Medicine and Research
|
November 24, 2025
Peridiaphragmatic inflammation and fibrosis in myositis associated interstitial lung disease; a case series
Joseph B Pryor, Joshua J Solomon, Jeffrey J Swigris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2026
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN study
A T Shaw, B J Solomon, E Felip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Daniel B Costa, Alice T Shaw, Sai-Hong I Ou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2024
Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survival
Scott M Matson, Linh T Ngo, Yui Sugawara, et al.
Page
of 139
Search research articles
Search
Showing results (1221-1230 of 1,388) with videos related to
Sort By:
Page
of 139
The Lancet. Oncology
|
October 28, 2017
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Alice T Shaw, Enriqueta Felip, Todd M Bauer, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Genetically-programmed Hypervesiculation of <i>Lactiplantibacillus plantarum</i> Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease Model
Nicholas H Pirolli, Daniel Levy, Alyssa Schledwitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 15, 2017
Exercise to preserve β-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) - a randomized controlled pilot trial
P Narendran, N Jackson, A Daley, et al.
Respiratory Medicine
|
April 22, 2017
High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival
Zulma X Yunt, Jonathan H Chung, Stephen Hobbs, et al.
Neurology. Clinical Practice
|
January 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS
Maria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, et al.
Heart Rhythm
|
April 27, 2005
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM
Katherine T Murray, Jeffrey N Rottman, Patrick G Arbogast, et al.
Respiratory Medicine and Research
|
November 24, 2025
Peridiaphragmatic inflammation and fibrosis in myositis associated interstitial lung disease; a case series
Joseph B Pryor, Joshua J Solomon, Jeffrey J Swigris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2026
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN study
A T Shaw, B J Solomon, E Felip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Daniel B Costa, Alice T Shaw, Sai-Hong I Ou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2024
Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survival
Scott M Matson, Linh T Ngo, Yui Sugawara, et al.
Page
of 139